Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9605-9615

  Li, Tingfeng ^a   Steede, N Kalaya ^a   Nguyen, Hong Nam P ^a   Freytag, Lucy C ^a   McLachlan, James B ^a   Mettu, Ramgopal R ^a   Robinson, James E ^b   Landry, Samuel J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; HLA ANTIGEN CLASS 2; PROTEIN BINDING;

ANIMAL; CBA MOUSE; CHEMISTRY; FEMALE; IMMUNOLOGY; METABOLISM; PROTEIN CONFORMATION; PROTEIN STABILITY;

ANIMALS; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV ENVELOPE PROTEIN GP120; MICE, INBRED CBA; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY;

EID: 84921975461     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00789-14     Document Type: Article

References (63)

1. Choi AH, Basu M, McNeal MM, Flint J, VanCott JL, Clements JD, Ward RL. 2000. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J. Virol. 74:11574-11580. http://dx.doi.org/10.1128/JVI.74.24.11574-11580.2000.
2. Zhao W, Pahar B, Sestak K. 2008. Identification of rotavirus VP6-specific CD4+ T cell epitopes in a G1P[8] human rotavirus-infected rhesus macaque. Virology (Auckl.) 1:9-15. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855136/.
3. McNeal MM, VanCott JL, Choi AH, Basu M, Flint JA, Stone SC, Clements JD, Ward RL. 2002. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J. Virol. 76:560-568. http://dx.doi.org/10.1128/JVI.76.2.560-568.2002.
4. Letvin NL, Rao SS, Montefiori DC, Seaman MS, Sun Y, Lim SY, Yeh WW, Asmal M, Gelman RS, Shen L, Whitney JB, Seoighe C, Lacerda M, Keating S, Norris PJ, Hudgens MG, Gilbert PB, Buzby AP, Mach LV, Zhang J, Balachandran H, Shaw GM, Schmidt SD, Todd JP, Dodson A, Mascola JR, Nabel GJ. 2011. Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci. Transl. Med. 3:81ra36. http://dx.doi.org/10.1126/scitranslmed.3002351.
5. Pahar B, Gray W, Phelps K, Didier E, deHaro E, Marx P, Traina-Dorge V. 2012. Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus-simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques. Virology J. 9:160. http://dx.doi.org/10.1186/1743-422X-9-160.
6. de Souza MS, Ratto-Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B, Valencia-Micolta A, Thelian D, Nitayaphan S, Pitisuttithum P, Paris RM, Kaewkungwal J, Michael NL, Rerks-Ngarm S, Mathieson B, Marovich M, Currier JR, Kim JH. 2012. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J. Immunol. 188: 5166-5176. http://dx.doi.org/10.4049/jimmunol.1102756.
7. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H. 2012. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci. Transl. Med. 4:123ra25. http://dx.doi.org/10.1126/scitranslmed.3003165.
8. Ranasinghe S, Flanders M, Cutler S, Soghoian DZ, Ghebremichael M, Davis I, Lindqvist M, Pereyra F, Walker BD, Heckerman D, Streeck H. 2012. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J. Virol. 86: 277-283. http://dx.doi.org/10.1128/JVI.05577-11.
9. Schulze zur Wiesch J, Lauer GM, Day CL, Kim AY, Ouchi K, Duncan JE, Wurcel AG, Timm J, Jones AM, Mothe B, Allen TM, McGovern B, Lewis-Ximenez L, Sidney J, Sette A, Chung RT, Walker BD. 2005. Broad repertoire of theCD4+Thcell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175:3603-3613. http://dx.doi.org/10.4049/jimmunol.175.6.3603.
10. Brenchley JM, Silvestri G, Douek DC. 2010. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 32: 737-742. http://dx.doi.org/10.1016/j.immuni.2010.06.004.
11. Ranasinghe S, Cutler S, Davis I, Lu R, Soghoian DZ, Qi Y, Sidney J, Kranias G, Flanders MD, Lindqvist M, Kuhl B, Alter G, Deeks SG, Walker BD, Gao X, Sette A, Carrington M, Streeck H. 2013. Association of HLA-DRB1-restricted CD4(+) T cell responses with HIV immune control. Nat. Med. 19:930-933. http://dx.doi.org/10.1038/nm.3229.
12. Watts C. 2004. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5:685-692. http://dx.doi.org/10.1038/ni1088.
13. Trombetta ES, Mellman I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23:975-1028. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104538.
14. Painter CA, Stern LJ. 2012. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications. Immunol. Rev. 250:144-157. http://dx.doi.org/10.1111/imr.12003.
15. Blum JS, Wearsch PA, Cresswell P. 2013. Pathways of antigen processing. Annu. Rev. Immunol. 31:443-473. http://dx.doi.org/10.1146/annurev-imm unol-032712-095910.
16. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203-213. http://dx.doi.org/10.1016/j.immuni.2007.07.007.
17. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B. 2008. A systematic assessment ofMHCclass II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4:e1000048. http://dx.doi.org/10.1371/journal.pcbi.1000048.
18. Peterson DA, DiPaolo RJ, Kanagawa O, Unanue ER. 1999. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11:453-462. http://dx.doi.org/10.1016/S1074-7613(00)80120-X.
19. Gelder C, Davenport M, Barnardo M, Bourne T, Lamb J, Askonas B, Hill A, Welsh K. 1998. Six unrelated HLA-DR-matched adults recognize identical CD4(+) T cell epitopes from influenza A haemagglutinin that are not simply peptides with high HLA-DR binding affinities. Int. Immunol. 10:211-222. http://dx.doi.org/10.1093/intimm/10.2.211.
20. Kim J, Sette A, Rodda S, Southwood S, Sieling PA, Mehra V, Ohmen JD, Oliveros J, Appella E, Higashimoto Y, Rea TH, Bloom BR, Modlin RL. 1997. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J. Immunol. 159:335-343.
21. Mirano-Bascos D, Tary-Lehmann M, Landry SJ. 2008. Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. Eur. J. Immunol. 38:1231-1237. http://dx.doi.org/10.1002/eji.200738011.
22. Dai G, Steede NK, Landry SJ. 2001. Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120. J. Biol. Chem. 276:41913-41920. http://dx.doi.org/10.1074/jbc.M106018200.
23. Surman S, Lockey TD, Slobod KS, Jones B, Riberdy JM, White SW, Doherty PC, Hurwitz JL. 2001. Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc. Natl. Acad. Sci. U. S. A. 98:4587-4592. http://dx.doi.org/10.1073/pnas.071063898.
24. Ziegler K, Unanue ER. 1981. Identification of a macrophage antigenprocessing event required for I-region-restricted antigen presentation to T lymphocytes. J. Immunol. 127:1869-1875.
25. Antoniou AN, Blackwood SL, Mazzeo D, Watts C. 2000. Control of antigen presentation by a single protease cleavage site. Immunity 12:391-398. http://dx.doi.org/10.1016/S1074-7613(00)80191-0.
26. Zhu H, Liu K, Cerny J, Imoto T, Moudgil KD. 2005. Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells. J. Immunol. 175:2252-2260. http://dx.doi.org/10.4049/jimmunol.175.4.2252.
27. Mutschlechner S, Egger M, Briza P, Wallner M, Lackner P, Karle A, Vogt AB, Fischer GF, Bohle B, Ferreira F. 2010. Naturally processed T cell-activating peptides of the major birch pollen allergen. J. Allergy Clin. Immunol. 125:711-718, 718.e1-718.e2. http://dx.doi.org/10.1016/j.jaci.2009.10.052.
28. West LC, Grotzke JE, Cresswell P. 2013. MHC class II-restricted presentation of the major house dust mite allergen Der p 1 Is GILT-dependent: implications for allergic asthma. PLoS One 8:e51343. http://dx.doi.org/10.1371/journal.pone.0051343.
29. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, Alfonso C, Karlsson L, Flavell RA, Cresswell P. 2001. Defective antigen processing in GILT-free mice. Science 294:1361-1365. http://dx.doi.org/10.1126/science.1065500.
30. Mirano-Bascos D, Steede NK, Robinson JE, Landry SJ. 2010. Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120. J. Virol. 84:3303-3311. http://dx.doi.org/10.1128/JVI.02242-09.
31. Hubbard SJ. 1998. The structural aspects of limited proteolysis of native proteins. Biochim. Biophys. Acta 1382:191-206. http://dx.doi.org/10.1016/S0167-4838(97)00175-1.
32. Hubbard SJ, Beynon RJ, Thornton JM. 1998. Assessment of conformational parameters as predictors of limited proteolysis sites in native protein structures. Protein Eng. 11:349-359. http://dx.doi.org/10.1093/protein/11.5.349.
33. Chang SG, Choi KD, Jang SH, Shin HC. 2003. Role of disulfide bonds in the structure and activity of human insulin. Mol. Cells 16:323-330.
34. van den Berg B, Chung EW, Robinson CV, Dobson CM. 1999. Characterisation of the dominant oxidative folding intermediate of hen lysozyme. J. Mol. Biol. 290:781-796. http://dx.doi.org/10.1006/jmbi.1999.2915.
35. Silvers R, Sziegat F, Tachibana H, Segawa S, Whittaker S, Günther UL, Gabel F, Huang JR, Blackledge M, Wirmer-Bartoschek J, Schwalbe H. 2012. Modulation of structure and dynamics by disulfide bond formation in unfolded states. J. Am. Chem. Soc. 134:6846-6854. http://dx.doi.org/10.1021/ja3009506.
36. Li P, Haque MA, Blum JS. 2002. Role of disulfide bonds in regulating antigen processing and epitope selection. J. Immunol. 169:2444-2450. http://dx.doi.org/10.4049/jimmunol.169.5.2444.
37. van Anken E, Sanders RW, Liscaljet IM, Land A, Bontjer I, Tillemans S, Nabatov AA, Paxton WA, Berkhout B, Braakman I. 2008. Only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the HIV-1 envelope glycoprotein. Mol. Biol. Cell 19:4298-4309. http://dx.doi.org/10.1091/mbc.E07-12-1282.
38. Pancera M, Majeed S, Ban YE, Chen L, Huang CC, Kong L, Kwon YD, Stuckey J, Zhou T, Robinson JE, Schief WR, Sodroski J, Wyatt R, Kwong PD. 2010. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc. Natl. Acad. Sci. U. S. A. 107:1166-1171. http://dx.doi.org/10.1073/pnas.0911004107.
39. Koradi R, Billeter M, Wuthrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55, 29-32. http://dx.doi.org/10.1016/0263-7855(96)00009-4.
40. Vertrees J, Barritt P, Whitten S, Hilser VJ. 2005. COREX/BEST server: a web browser-based program that calculates regional stability variations within protein structures. Bioinformatics 21:3318-3319. http://dx.doi.org/10.1093/bioinformatics/bti520.
41. Hilser VJ, Freire E. 1996. Structure-based calculation of the equilibrium folding pathway of proteins. Correlation with hydrogen exchange protection factors. J. Mol. Biol. 262:756-772.
42. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
43. Landry SJ. 2008. Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin. J. Virol. 82:1238-1248. http://dx.doi.org/10.1128/JVI.02026-07.
44. Cardenas-Freytag L, Cheng E, Mayeux P, Domer JE, Clements JD. 1999. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect. Immun. 67:826-833.
45. Nielsen M, Lund O. 2009. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 10:296. http://dx.doi.org/10.1186/1471-2105-10-296.
46. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. 2010. The immune epitope database 2.0. Nucleic Acids Res. 38:D854-D862. http://dx.doi.org/10.1093/nar/gkp1004.
47. Nelson CA, Viner NJ, Young SP, Petzold SJ, Unanue ER. 1996. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak. J. Immunol. 157:755-762.
48. Fremont DH, Monnaie D, Nelson CA, Hendrickson WA, Unanue ER. 1998. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 8:305-317. http://dx.doi.org/10.1016/S1074-7613(00) 80536-1.
49. Raska M, Takahashi K, Czernekova L, Zachova K, Hall S, Moldoveanu Z, Elliott MC, Wilson L, Brown R, Jancova D, Barnes S, Vrbkova J, Tomana M, Smith PD, Mestecky J, Renfrow MB, Novak J. 2010. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J. Biol. Chem. 285:20860-20869. http://dx.doi.org/10.1074/jbc.M109.085472.
50. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623-1631. http://dx.doi.org/10.1084/jem.186.10.1623.
51. Tudor D, Dubuquoy C, Gaboriau V, Lefevre F, Charley B, Riffault S. 2005. TLR9pathway is involved in adjuvant effects of plasmid DNA-based vaccines. Vaccine 23:1258-1264. http://dx.doi.org/10.1016/j.vaccine.2004.09.001.
52. Ma C, Whiteley PE, Cameron PM, Freed DC, Pressey A, Chen SL, Garni-Wagner B, Fang C, Zaller DM, Wicker LS, Blum JS. 1999. Role of APC in the selection of immunodominant T cell epitopes. J. Immunol. 163:6413-6423.
53. Phelps RG, Jones VL, Coughlan M, Turner AN, Rees AJ. 1998. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. J. Biol. Chem. 273:11440-11447. http://dx.doi.org/10.1074/jbc.273.19.11440.
54. Pollard SR, Meier W, Chow P, Rosa JJ, Wiley DC. 1991. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion. Proc. Natl. Acad. Sci. U. S. A. 88:11320-11324. http://dx.doi.org/10.1073/pnas.88.24.11320.
55. Jaworski JP, Krebs SJ, Trovato M, Kovarik DN, Brower Z, Sutton WF, Waagmeester G, Sartorius R, D'Apice L, Caivano A, Doria-Rose NA, Malherbe D, Montefiori DC, Barnett S, De Berardinis P, Haigwood NL. 2012. Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies andCD8+T cells. PLoS One 7:e31464. http://dx.doi.org/10.1371/journal.pone.0031464.
56. Li J, Valentin A, Kulkarni V, Rosati M, Beach RK, Alicea C, Hannaman D, Reed SG, Felber BK, Pavlakis GN. 2013. HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. Vaccine 31:3747-3755. http://dx.doi.org/10.1016/j.vaccine.2013.04.037.
57. Walsh KP, Mills KH. 2013. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 34:521-530. http://dx.doi.org/10.1016/j.it.2013.07.006.
58. Yamane H, Paul WE. 2013. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol. Rev. 252:12-23. http://dx.doi.org/10.1111/imr.12032.
59. Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. 2009. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 123:1047-1054. http://dx.doi.org/10.1016/j.jaci.2009.02.026.
60. Hongjia L, Caiqing Z, Degan L, Fen L, Chao W, Jinxiang W, Liang D. 2014. IL-25 promotes Th2 immunity responses in airway inflammation of asthmatic mice via activation of dendritic cells. Inflammation http://dx.doi.org/10.1007/s10753-014-9830-4.
61. Donermeyer DL, Allen PM. 1989. Binding to Ia protects an immunogenic peptide from proteolytic degradation. J. Immunol. 142:1063-1068.
62. Mouritsen S, Meldal M, Werdelin O, Hansen AS, Buus S. 1992. MHC molecules protect T cell epitopes against proteolytic destruction. J. Immunol. 149:1987-1993.
63. von Delwig A, Musson JA, Gray J, McKie N, Robinson JH. 2005. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells. Immunology 114:194-203. http://dx.doi.org/10.1111/j.1365-2567.2004.02085.x.